公开(公告)号：US20130245084A1

公开(公告)日：2013-09-19

申请号：US13989447

申请日：2011-11-21

Applicant: Kristoffer Mansson

Inventor： Kristoffer Mansson

IPC: C07D249/10 ,  C07C317/28 ,  C07C237/34

CPC classification number: C07D249/10 ,  C07C229/46 ,  C07C237/34 ,  C07C317/28 ,  C07C317/44 ,  C07C2601/08

Abstract: Compounds of general formula (I) their use as calcium receptor-active compounds for the prophylaxis, treatment or amelioration of physiological disorders or diseases associated with disturbances of CaSR activity, such as hyperparathyroidism, pharmaceutical compositions comprising said compounds, and methods of treating diseases with said compounds.

Abstract translation: 通式（I）的化合物作为钙受体活性化合物用于预防，治疗或改善与CaSR活性相关的生理障碍或疾病如甲状旁腺功能亢进，包含所述化合物的药物组合物和用于治疗疾病的方法 所述化合物。